HIV/AIDS Vaccine
Modified rabies virus vectors safe, effective
Published in Vaccine Weekly, January 8th, 2003
RV-based vectors "show great promise as vaccines against other viral diseases such as human immunodeficiency virus type 1 (HIV-1) infection and hepatitis C, but a low residual pathogenicity remains a concern for their use," explained James P. McGettigan and colleagues at Thomas Jefferson University in Philadelphia.
A series of second-generation RV-based vaccines have been rendered apathogenic without sacrificing their antiviral efficacy, McGettigan and coauthors said.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2003-01-08)
More Articles from Vaccine Weekly
- Cancer Vaccine
DNA vaccine elicits humoral and cellular immune responses in lymphoma patients - Diabetes Vaccine
Intranasal vaccine delays onset of autoimmune diabetes in mice - Cancer Vaccine
Pancreatic cancer research should focus on antigen presentation, targeted drug delivery - Infectious Disease Vaccine
Bacterial meningitis vaccine elicits protective antibody production - Vaccine Adjuvant
Pancreatic cancer research should focus on antigen presentation, targeted drug delivery - Vaccine Development
Complete DNA sequences of Oka varicella vaccine and its parental virus compared - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
